宫腔粘连 中国就医指南

Intrauterine adhesions (IUA), also known as Asherman’s syndrome, are fibrous bands of scar tissue that form within the uterine cavity, leading to partial or complete obliteration of the endometrial space. These adhesions result from trauma-induced damage to the basal layer of the endometrium—most commonly following dilation and curettage (D&C) after miscarriage or postpartum hemorrhage, but also after uterine surgery (e.g., myomectomy, cesarean section), infection (chronic endometritis), or radiation therapy. Pathogenesis centers on defective re-epithelialization: injury disrupts the delicate balance between tissue repair and fibrosis, triggering excessive collagen deposition by activated fibroblasts and myofibroblasts, often exacerbated by impaired angiogenesis and reduced stem cell recruitment in the damaged endometrium. Epidemiologically, IUA affects an estimated 1.5–22% of women undergoing D&C for pregnancy-related complications, with higher prevalence (up to 30%) among those with recurrent pregnancy loss or repeated uterine instrumentation. Risk factors include multiple D&Cs, surgical termination in the second trimester, history of pelvic tuberculosis (especially in endemic regions), severe intrauterine infection, and possibly genetic predisposition to aberrant wound healing. Clinically, symptoms range from amenorrhea or hypomenorrhea (most common), cyclic pelvic pain (due to trapped menstrual blood), infertility, and recurrent pregnancy loss—though some cases remain asymptomatic until fertility evaluation. The condition profoundly impacts quality of life: women often experience emotional distress, anxiety about fertility, sexual dysfunction due to pain or fear of conception failure, and diminished self-perception related to reproductive identity. Untreated IUA carries high risks of obstetric complications—including placenta accreta spectrum disorders, preterm birth, and intrauterine growth restriction—if pregnancy occurs. Early diagnosis via saline infusion sonohysterography (SIS) or hysteroscopy is critical; hysteroscopy remains the gold standard for both diagnosis and therapeutic intervention. Management aims not only to restore uterine anatomy but also to regenerate functional endometrium—requiring a multimodal approach combining mechanical adhesiolysis, intrauterine barrier placement (e.g., hyaluronic acid gel or balloon catheter), hormonal support (estrogen-progesterone regimens), and sometimes adjunctive therapies like platelet-rich plasma (PRP) or stem cell applications in refractory cases. Long-term follow-up with repeat hysteroscopy is essential to assess endometrial recovery and prevent recurrence, which occurs in 20–62% of moderate-to-severe cases without optimal adjuvant therapy.

# 宫腔粘连治疗方案与费用明细（生殖医学科）

一、非手术保守治疗（轻度粘连、术后预防、备孕前调理）

• •适用人群：IUA评分≤4分、无明显宫腔变形、有生育意愿但暂不手术者
• •方案构成：雌激素周期治疗（戊酸雌二醇+黄体酮）+宫腔灌注（透明质酸钠/羊膜提取液）+盆底生物反馈理疗
• •费用区间：

- 宫腔灌注（6次）：3,600–7,200元 - 盆底理疗（12次）：2,400–4,800元 - 必查项目（超声造影+性激素六项+感染筛查）：1,150–1,680元

二、手术治疗（核心介入方案）

• •适用人群：IUA评分≥5分、宫腔形态异常、既往妊娠失败或闭经者
• •术式：宫腔镜下粘连松解术（冷刀/微型剪为主，禁用电切以防热损伤）+防粘连屏障置入（医用几丁糖/透明质酸凝胶）
• •费用区间：

- 手术费+麻醉费+耗材（含防粘连材料）：12,000–22,000元 - 术后激素序贯治疗（3个月）：1,500–3,000元

三、复杂/复发/重度治疗方案

• •适用人群：重度粘连（IUA≥8分）、≥2次复发、合并子宫内膜萎缩或Asherman综合征
• •方案：宫腔镜二次松解+干细胞宫腔灌注（临床研究路径）+个体化激素重建+IVF助孕衔接管理
• •费用区间：28,000–52,000元（含干细胞制备、动态内膜监测、多周期管理）

四、方案快速选择指南

• •预算有限/初发轻度：首选保守治疗（总预算≤1.2万元）
• •中重度/有生育急迫需求：直接宫腔镜手术（推荐三甲生殖中心，总预算1.8–3.2万元）
• •反复复发/内膜极薄：转入复杂方案，同步启动辅助生殖规划（预算≥3.5万元）